Eledon Pharmaceuticals Inc (ELDN)

Mar 11, 2025

Institutional investors in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) see US$25m decrease in market cap last week, although long-term gains have benefitted them. - Simply Wall St

Mar 11, 2025

Mar 05, 2025

Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference - GlobeNewswire

Mar 05, 2025

Mar 04, 2025

When Can You Hear Eledon's Latest Strategic Updates? Key Conference Appearance Scheduled - StockTitan

Mar 04, 2025

Feb 19, 2025

Eledon Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Feb 19, 2025

Feb 17, 2025

Eledon Touts Tegoprubart Used in Pig Kidney Transplant - Orange County Business Journal

Feb 17, 2025

Feb 17, 2025

Before You Invest, Make Sure You Check This Eledon Pharmaceuticals Inc (NASDAQ: ELDN) Analysis - Stocks Register

Feb 17, 2025

Feb 13, 2025

Leerink Partnrs Has Pessimistic Outlook of ELDN Q4 Earnings - MarketBeat

Feb 13, 2025

Feb 11, 2025

Eledon's tegoprubart used in second pig-to-human kidney transplant - MSN

Feb 11, 2025

Feb 11, 2025

Leerink Partnrs Issues Negative Outlook for ELDN Earnings - Defense World

Feb 11, 2025

Feb 07, 2025

Eledon's tegoprubart used in second pig-to-human kidney transplant By Investing.com - Investing.com South Africa

Feb 07, 2025

Feb 07, 2025

Eledon Pharmaceuticals Announces Use of Tegoprubart as Key - GlobeNewswire

Feb 07, 2025

Feb 07, 2025

Eledon announces tegoprubart use in transplant of pig kidney into human - TipRanks

Feb 07, 2025

Feb 07, 2025

Revolutionary Xenotransplant Success: Eledon Drug Enables Patient Freedom from Dialysis - StockTitan

Feb 07, 2025

Feb 07, 2025

FY2029 Earnings Estimate for ELDN Issued By Leerink Partnrs - Armenian Reporter

Feb 07, 2025

Jan 31, 2025

Eledon Pharmaceuticals (NASDAQ:ELDN) Coverage Initiated by Analysts at Guggenheim - MarketBeat

Jan 31, 2025

Jan 30, 2025

Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech Conference - The Manila Times

Jan 30, 2025

Jan 29, 2025

Eledon CEO to Reveal Latest Biotech Developments at Major Guggenheim Conference - StockTitan

Jan 29, 2025

Jan 28, 2025

Eledon Pharmaceuticals: At The Forefront Of The Organ Transplant Management Business - Seeking Alpha

Jan 28, 2025

Jan 28, 2025

Guggenheim Initiates Eledon Pharmaceuticals at Buy With $9 Price Target -January 28, 2025 at 07:34 am EST - Marketscreener.com

Jan 28, 2025

Jan 25, 2025

Inspire Investing LLC Invests $802,000 in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - MarketBeat

Jan 25, 2025

Jan 24, 2025

Midday Stock Roundup: FivePoint Holdings Jumps 36% - Orange County Business Journal

Jan 24, 2025

Jan 23, 2025

Cantor Fitzgerald Comments on ELDN FY2025 Earnings - Defense World

Jan 23, 2025

Jan 22, 2025

Kidney Transplant Rejection Market Expected to Experience - openPR

Jan 22, 2025

Jan 22, 2025

Cantor Fitzgerald Weighs in on ELDN FY2025 Earnings - MarketBeat

Jan 22, 2025

Jan 20, 2025

Analyst Forecast For Eledon Pharmaceuticals Inc (NASDAQ: ELDN) - Stocks Register

Jan 20, 2025

Jan 14, 2025

Eledon Pharmaceuticals highlights recent business milestones, 2025 outlook - MSN

Jan 14, 2025

Jan 13, 2025

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook - GlobeNewswire

Jan 13, 2025

Jan 13, 2025

Eledon's Tegoprubart Achieves Major Breakthrough in Kidney Transplant Trials, Secures $135M Funding - StockTitan

Jan 13, 2025

Jan 11, 2025

Geode Capital Management LLC Buys 33,569 Shares of Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - Defense World

Jan 11, 2025

Jan 07, 2025

Eledon Pharmaceuticals (NASDAQ:ELDN) Trading Down 3.9%Should You Sell? - MarketBeat

Jan 07, 2025

Dec 20, 2024

Eledon Pharmaceuticals adjusts CEO bonus structure - Investing.com

Dec 20, 2024

Dec 16, 2024

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Short Interest Update - MarketBeat

Dec 16, 2024

Nov 24, 2024

Eledon Pharmaceuticals (NASDAQ:ELDN) Earns “Buy” Rating from HC Wainwright - Defense World

Nov 24, 2024

Nov 23, 2024

HC Wainwright Has Negative Outlook for ELDN Q4 Earnings - Defense World

Nov 23, 2024

Nov 22, 2024

HC Wainwright Issues Pessimistic Forecast for ELDN Earnings - MarketBeat

Nov 22, 2024

Nov 21, 2024

Eledon Pharmaceuticals retains shares target, Buy rating on clinical trial progress - Investing.com Australia

Nov 21, 2024

Nov 20, 2024

Eledon Pharmaceuticals retains shares target, Buy rating on clinical trial progress By Investing.com - Investing.com South Africa

Nov 20, 2024

Nov 20, 2024

Eledon Pharmaceuticals (NASDAQ:ELDN) Given Buy Rating at HC Wainwright - MarketBeat

Nov 20, 2024

Nov 18, 2024

FY2024 EPS Estimates for ELDN Boosted by Cantor Fitzgerald - MarketBeat

Nov 18, 2024

Nov 15, 2024

Lifesci Capital Issues Optimistic Outlook for ELDN Earnings - MarketBeat

Nov 15, 2024